Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters

Next Previous
Trial Profile

Natesto Effects on Testosterone, Luteinizing Hormone, Follicle Stimulating Hormone and Semen Parameters

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Oct 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 21 Oct 2020 Results of a post hoc analysis assessing the predictors of changes in semen parameters in men who received Natesto, presented at the American Society for Reproductive Medicine Scientific Congress 2020
    • 20 Aug 2020 All the primary end-points have been updated with a changed time-frame, few end-points like serum analysis, Sexual Health Inventory in Men (SHIM)- have been removed, while the others have been modified and a new safety/adverse-reaction end-point is added.
    • 03 Jun 2020 Status changed from active, no longer recruiting to completed.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top